Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors
Abstract The inconsistencies in the performance of the virtual screening (VS) process, depending on the used software and structural conformation of the protein, is a challenging issue in the drug design and discovery field. Varying performance, especially in terms of early recognition of the potent...
Guardado en:
Autores principales: | Garri Chilingaryan, Narek Abelyan, Arsen Sargsyan, Karen Nazaryan, Andre Serobian, Hovakim Zakaryan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/723fa34d85bd42ff9cba9172a8c7d336 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery
por: Mohammad M. Al-Sanea, et al.
Publicado: (2021) -
Correction to: Class‑II dihydroorotate dehydrogenases from three phylogenetically distant fungi support anaerobic pyrimidine biosynthesis
por: Jonna Bouwknegt, et al.
Publicado: (2021) -
Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies.
por: Julia Penna-Coutinho, et al.
Publicado: (2011) -
Pharmakinetics studies, molecular docking and discovery of anti- proliferative agents and its targeting EGFR inhibitors
por: Palanisamy Prakash, et al.
Publicado: (2022) -
DOCKING OF TYROSINASE CICLOARTANE INHIBITORS
por: Pablo A. GUTIÉRREZ, et al.
Publicado: (2009)